NDC product
mucus relief DM MAX
NDC 11822-1812 · Rite Aid Corporation
Key facts
| Product NDC | 11822-1812 |
|---|---|
| Proprietary name | mucus relief DM MAX |
| Nonproprietary name | dextromethorphan HBr, guaifenesin |
| Substances | GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Rite Aid Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA207602 |
| Pharmacologic classes | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] and 1 more |
| Marketing start | Mar 13, 2023 |
| Marketing end | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory